These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

94 related items for PubMed ID: 30193444

  • 1. [THE ROLE OF THE ENDOGENOUS CANNABINOID SYSTEM IN THE FORMATION OF THE GENERAL ADAPTATION SYNDROME].
    Krylatov AV, Serebrov VY.
    Ross Fiziol Zh Im I M Sechenova; 2016 Nov; 102(11):1265-79. PubMed ID: 30193444
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. The role of endogenous cannabinoids in the hypothalamo-pituitary-adrenal axis regulation: in vivo and in vitro studies in CB1 receptor knockout mice.
    Barna I, Zelena D, Arszovszki AC, Ledent C.
    Life Sci; 2004 Oct 29; 75(24):2959-70. PubMed ID: 15454346
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Endocannabinoid hydrolase and cannabinoid receptor 1 are involved in the regulation of hypothalamus-pituitary-adrenal axis in type 2 diabetes.
    Luo Q, Chen S, Deng J, Shi L, Huang C, Cheng A, Liu W, Fang J, Tang L, Geng Y, Chen Z.
    Metab Brain Dis; 2018 Oct 29; 33(5):1483-1492. PubMed ID: 29948652
    [Abstract] [Full Text] [Related]

  • 9. Requirement of cannabinoid receptor type 1 for the basal modulation of hypothalamic-pituitary-adrenal axis function.
    Cota D, Steiner MA, Marsicano G, Cervino C, Herman JP, Grübler Y, Stalla J, Pasquali R, Lutz B, Stalla GK, Pagotto U.
    Endocrinology; 2007 Apr 29; 148(4):1574-81. PubMed ID: 17194743
    [Abstract] [Full Text] [Related]

  • 10. Prostaglandins and interleukin-1beta in the hypothalamic-pituitary-adrenal response to systemic phenylephrine under basal and stress conditions.
    Gadek-Michalska A, Bugajski AJ, Bugajski J.
    J Physiol Pharmacol; 2008 Sep 29; 59(3):563-75. PubMed ID: 18953098
    [Abstract] [Full Text] [Related]

  • 11. Sympathetic nervous system contributes to enhanced corticosterone levels following chronic stress.
    Lowrance SA, Ionadi A, McKay E, Douglas X, Johnson JD.
    Psychoneuroendocrinology; 2016 Jun 29; 68():163-70. PubMed ID: 26974501
    [Abstract] [Full Text] [Related]

  • 12. Chronic stress adaptation of the nitric oxide synthases and IL-1β levels in brain structures and hypothalamic-pituitary-adrenal axis activity induced by homotypic stress.
    Gadek-Michalska A, Tadeusz J, Rachwalska P, Bugajski J.
    J Physiol Pharmacol; 2015 Jun 29; 66(3):427-40. PubMed ID: 26084225
    [Abstract] [Full Text] [Related]

  • 13. Monoaminergic neurotransmission contributes to cannabinoid-induced activation of the hypothalamic-pituitary-adrenal axis.
    McLaughlin RJ, Hill MN, Gorzalka BB.
    Eur J Pharmacol; 2009 Dec 10; 624(1-3):71-6. PubMed ID: 19818759
    [Abstract] [Full Text] [Related]

  • 14. Involvement of prostaglandins in the nicotine-induced pituitary-adrenocortical response during social stress.
    Bugajski J, Gadek-Michalska A, Bugajski AJ.
    J Physiol Pharmacol; 2002 Dec 10; 53(4 Pt 2):847-57. PubMed ID: 12510868
    [Abstract] [Full Text] [Related]

  • 15. The vasopressin V1b receptor critically regulates hypothalamic-pituitary-adrenal axis activity under both stress and resting conditions.
    Tanoue A, Ito S, Honda K, Oshikawa S, Kitagawa Y, Koshimizu TA, Mori T, Tsujimoto G.
    J Clin Invest; 2004 Jan 10; 113(2):302-9. PubMed ID: 14722621
    [Abstract] [Full Text] [Related]

  • 16. Activation of PPAR-γ reduces HPA axis activity in diabetic rats by up-regulating PI3K expression.
    Torres RC, Magalhães NS, E Silva PM, Martins MA, Carvalho VF.
    Exp Mol Pathol; 2016 Oct 10; 101(2):290-301. PubMed ID: 27725163
    [Abstract] [Full Text] [Related]

  • 17. Sensitization of the Hypothalamic-Pituitary-Adrenal Axis in a Male Rat Chronic Stress Model.
    Franco AJ, Chen C, Scullen T, Zsombok A, Salahudeen AA, Di S, Herman JP, Tasker JG.
    Endocrinology; 2016 Jun 10; 157(6):2346-55. PubMed ID: 27054552
    [Abstract] [Full Text] [Related]

  • 18. Activation of the hypothalamo-pituitary-adrenal axis by the growth hormone (GH) secretagogue, GH-releasing peptide-6, in rats.
    Thomas GB, Fairhall KM, Robinson IC.
    Endocrinology; 1997 Apr 10; 138(4):1585-91. PubMed ID: 9075719
    [Abstract] [Full Text] [Related]

  • 19. CB1 receptor-deficient mice as a model for depression.
    Valverde O, Torrens M.
    Neuroscience; 2012 Mar 01; 204():193-206. PubMed ID: 21964469
    [Abstract] [Full Text] [Related]

  • 20. Chronic brain glucocorticoid receptor blockade enhances the rise in circadian and stress-induced pituitary-adrenal activity.
    van Haarst AD, Oitzl MS, Workel JO, de Kloet ER.
    Endocrinology; 1996 Nov 01; 137(11):4935-43. PubMed ID: 8895366
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.